Search AI Products and News

Alibaba's AI model, DAMO PANDA, has been officially designated a breakthrough medical device by the U.S. Food and Drug Administration (FDA). This certification marks a significant breakthrough for Alibaba in the field of AI-powered healthcare and represents the first time a leading Chinese tech company has received this prestigious recognition. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model designed for pancreatic cancer screening. It aims to accurately identify subtle lesions in CT images, aiding in early detection of the disease.

A groundbreaking AI-powered ultrasound technology has won a million-dollar prize, promising a revolution in heart health diagnostics and paving the way for more accessible and accurate cardiac care.

At the recent Geek Park IF2025 Innovation Conference, Wang Xiaochuan, founder and CEO of BaiChuan Intelligence, had a dialogue with Zhang Peng, founder of Geek Park, elaborating on his in-depth thoughts on the medical field, AGI (Artificial General Intelligence), and technological progress. Wang Xiaochuan reflected on his original intention to choose the medical sector, which is both a dream of his involvement in life sciences and a decision made after rational consideration. As early as 2000, during his graduate studies, Wang Xiaochuan began to engage with life sciences and developed a strong interest in the mathematical models behind life.

According to the Shanghai Municipal Science and Technology Commission, Shanghai has once again set a new record in medical technology. On November 6, Huashan Hospital's neurosurgery department successfully completed a pioneering clinical implant trial of a brain-computer interface, bringing hope to paralyzed patients for regaining autonomy in their lives. This groundbreaking technology was jointly developed by Borye Medical Technology and Professor Hongbo's team from Tsinghua University. Patient Xiao Dong, after being paralyzed for four years, successfully collected neural signals from the sensory-motor area of the brain using a brain-computer interface device the size of a coin. Unlike traditional invasive brain-computer interfaces, this system employs a wireless minimally invasive design.

Recent research has found that using artificial intelligence (AI) software can significantly improve the detection speed of large vessel occlusion (LVO) in stroke patients, thereby shortening treatment times and potentially improving treatment outcomes. Through clinical trials at four comprehensive stroke centers, researchers discovered that the automated system was associated with a 60% reduction in mortality rates. This study evaluated the effectiveness of using automated software to detect LVO from computed tomography (CT) angiography images. The research found that after the introduction of the AI system, the process for treating patients in the hospital was streamlined.